Jin Su Kim Selected Research

131I-rituximab

1/2021	Diacerein, an inhibitor of IL-1β downstream mediated apoptosis, improves radioimmunotherapy in a mouse model of Burkitt's lymphoma.
10/2019	Improved Quantification of 18F-FDG PET during 131I-Rituximab Therapy on Mouse Lymphoma Models after 131I Prompt Emission Correction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin Su Kim Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 01/2010
7	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2013
7	Hemorrhage 01/2019 - 01/2014
5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2016
4	Hallux Valgus 12/2017 - 08/2013
4	Gastroesophageal Reflux (GERD) 08/2017 - 07/2012
3	Lymphoma (Lymphomas) 01/2021 - 10/2019
3	Memory Disorders (Memory Loss) 07/2020 - 01/2012
3	Crohn Disease (Crohn's Disease) 01/2020 - 09/2015
3	Myocardial Infarction 01/2020 - 02/2016
3	Wounds and Injuries (Trauma) 01/2019 - 05/2013
3	Infections 09/2015 - 02/2014
3	Pain (Aches) 06/2013 - 05/2012
2	Cognitive Dysfunction 10/2021 - 01/2016
2	Polyps 07/2021 - 08/2014
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2021 - 05/2020
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
2	Alopecia (Baldness) 02/2019 - 02/2019
2	Chemotherapy-Related Cognitive Impairment 02/2019 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 11/2018
2	Inflammation (Inflammations) 11/2018 - 01/2013
2	Parkinson Disease (Parkinson's Disease) 01/2018 - 01/2015
2	Infarction (Infarctions) 12/2016 - 02/2016
2	Colorectal Neoplasms (Colorectal Cancer) 11/2016 - 08/2014
2	Ischemic Stroke 06/2014 - 01/2013
2	Ischemia 06/2014 - 01/2013
2	Nausea 05/2014 - 04/2013
2	Vomiting 05/2014 - 04/2013
1	Autism Spectrum Disorder 01/2022
1	COVID-19 12/2021
1	Rheumatoid Arthritis 01/2021
1	Stress Fractures (Stress Fracture) 11/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Hearing Loss (Hearing Impairment) 01/2020
1	Conductive Hearing Loss 01/2020
1	Gallstones (Gallstone) 01/2020

Drug/Important Bio-Agent (IBA)

7	Monoclonal AntibodiesIBA 01/2022 - 06/2016
6	Trastuzumab (Herceptin)FDA Link 10/2021 - 02/2019
5	Neuroprotective AgentsIBA 07/2020 - 01/2013
5	Capsules (Microcapsules)IBA 01/2020 - 01/2013
4	Peptides (Polypeptides)IBA 01/2020 - 10/2016
4	AcidsIBA 08/2017 - 07/2012
4	CollagenIBA 12/2016 - 02/2016
3	Atorvastatin (Lipitor)FDA Link 10/2021 - 02/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2008
3	Radioisotopes (Radionuclides)IBA 11/2019 - 06/2016
3	AntioxidantsIBA 02/2019 - 01/2013
3	17- N,N- diethylcarbamoyl- 4- methyl- 4- azaandrostane- 3- one (DMAA)IBA 11/2016 - 08/2013
2	MicroplasticsIBA 01/2022 - 01/2022
2	131I-rituximabIBA 01/2021 - 10/2019
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2021
2	PhosphatidylserinesIBA 07/2020 - 01/2012
2	Rituximab (Mabthera)FDA Link 05/2020 - 10/2019
2	Neoplasm Antigens (Tumor Antigens)IBA 11/2019 - 06/2016
2	AntigensIBA 09/2019 - 06/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 01/2013
2	Bee Venoms (Bee Venom)IBA 11/2018 - 01/2016
2	Phospholipases A2 (Phospholipase A2)IBA 11/2018 - 01/2016
2	Amyloid beta-PeptidesIBA 11/2018 - 10/2016
2	Biological ProductsIBA 11/2018 - 01/2018
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2018 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 12/2013
2	Proton Pump InhibitorsIBA 04/2013 - 07/2012
1	Losartan (Cozaar)FDA LinkGeneric 12/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 07/2021
1	diacereinIBA 01/2021
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2021
1	Drug CombinationsIBA 01/2021
1	atelocollagenIBA 11/2020
1	Cholinergic Agents (Cholinergics)IBA 07/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Interleukin-12 (IL 12)IBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	RelaxinIBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2019
1	IronIBA 02/2019

Therapy/Procedure

17	Therapeutics 01/2022 - 07/2012
6	Radioimmunotherapy 01/2021 - 06/2016
4	Self Expandable Metallic Stents 01/2020 - 07/2013
3	Drug Therapy (Chemotherapy) 02/2019 - 01/2016
3	Endoscopes 01/2019 - 02/2014
3	Osteotomy 12/2017 - 01/2011
2	Catheters 01/2020 - 08/2019
2	Transplantation 01/2020 - 03/2015
2	Gastrectomy 01/2019 - 01/2010
2	Radiotherapy 11/2018 - 05/2014
2	Fecal Microbiota Transplantation 04/2017 - 03/2015
2	Palliative Care (Palliative Therapy) 11/2016 - 07/2013
2	Stents 11/2016 - 08/2014
2	Appendectomy 05/2013 - 01/2013
1	Cell Transplantation 01/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Capsule Endoscopes 01/2020
1	Immunotherapy 11/2019
1	Injections 09/2019